AZD-4956

N/A

Report date: 2026/03/28 20:00:32
NME

Base Information

Drug NameAZD-4956
Drug Alias NameAZD4956AZD-4956
ClassificationOther
Mechanisms of ActionProbable global transcription activator SNF2L2 inhibitors
TargetsProbable global transcription activator SNF2L2
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustraliaUnited Kingdom +[6] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesAstrazeneca Plc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A